| Jerry W Smartt Jr, MD | |
|
9640 Commerce Dr, Suite 412, Carmel, IN 46032-7640 | |
| (317) 872-4545 | |
| (317) 872-3959 |
| Full Name | Jerry W Smartt Jr |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 24 Years |
| Location | 9640 Commerce Dr, Carmel, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306850722 | NPI | - | NPPES |
| 200506690 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 01058330A (Indiana) | Primary |
| Entity Name | Smartt Neurology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053505826 PECOS PAC ID: 9931165826 Enrollment ID: O20071017000009 |
News Archive
Agents believed to selectively "restart" genes that limit cancer's growth - a potential treatment option already in early clinical studies - instead turn off as many genes as they turn on, a team of researchers from the National Cancer Institute and Johns Hopkins has discovered.
Children in Somaliland suffer a significant burden of health conditions - particularly congenital deformities and wound-related conditions - that could be bettered by surgery, but most of these needs are being unmet, according to a study by Baylor University and Duke University published in the Journal of the American Medical Association.
OSI Pharmaceuticals, Inc. announced today that it has completed enrollment in the RADIANT study, a Phase III clinical trial testing Tarceva (erlotinib) as an adjuvant therapy in patients with Stage IB-IIIA non-small cell lung cancer who have undergone surgery and have EGFR-positive tumors.
An Associated Press examination of her care highlights the dizzying array of federal, state and private agencies charged with regulating hospital care, and the differing standards they use when investigating the most serious cases of possible neglect. In addition, an investigation report filed by Virginia regulators appears to have been altered to delete parts of the report that substantiated most of the family's complaints. That prompted a former top federal regulator to say the case warrants further investigation.
Benign growth, or cancer? Tumor markers in the blood help determine whether the patient is afflicted with a malign tumor and whether it is excreting markers more vigorously - involving highly specific proteins. An increased concentration in the blood provides one indication of the disease for physicians. However, it has been quite expensive in time and effort to detect the markers thus far. This is because all kinds of molecules and proteins are teeming in the blood. To be able to detect a single specific one, doctors must first separate and purify the blood in several steps, and then isolate the marker they are searching for from the rest of the molecules.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jerry W Smartt Jr, MD 9640 Commerce Dr, Suite 412, Carmel, IN 46032-7640 Ph: (317) 872-4545 | Jerry W Smartt Jr, MD 9640 Commerce Dr, Suite 412, Carmel, IN 46032-7640 Ph: (317) 872-4545 |
News Archive
Agents believed to selectively "restart" genes that limit cancer's growth - a potential treatment option already in early clinical studies - instead turn off as many genes as they turn on, a team of researchers from the National Cancer Institute and Johns Hopkins has discovered.
Children in Somaliland suffer a significant burden of health conditions - particularly congenital deformities and wound-related conditions - that could be bettered by surgery, but most of these needs are being unmet, according to a study by Baylor University and Duke University published in the Journal of the American Medical Association.
OSI Pharmaceuticals, Inc. announced today that it has completed enrollment in the RADIANT study, a Phase III clinical trial testing Tarceva (erlotinib) as an adjuvant therapy in patients with Stage IB-IIIA non-small cell lung cancer who have undergone surgery and have EGFR-positive tumors.
An Associated Press examination of her care highlights the dizzying array of federal, state and private agencies charged with regulating hospital care, and the differing standards they use when investigating the most serious cases of possible neglect. In addition, an investigation report filed by Virginia regulators appears to have been altered to delete parts of the report that substantiated most of the family's complaints. That prompted a former top federal regulator to say the case warrants further investigation.
Benign growth, or cancer? Tumor markers in the blood help determine whether the patient is afflicted with a malign tumor and whether it is excreting markers more vigorously - involving highly specific proteins. An increased concentration in the blood provides one indication of the disease for physicians. However, it has been quite expensive in time and effort to detect the markers thus far. This is because all kinds of molecules and proteins are teeming in the blood. To be able to detect a single specific one, doctors must first separate and purify the blood in several steps, and then isolate the marker they are searching for from the rest of the molecules.
› Verified 3 days ago
William N. Arnold, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 38 Twinshore Ct, Carmel, IN 46033 Phone: 317-796-8316 | |
Dr. Danita Lynn Lively, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 703 Pro-med Ln, Carmel, IN 46032 Phone: 317-844-0055 Fax: 317-581-3918 | |
Michael A Webber, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 703 Pro-med Ln, Carmel, IN 46032 Phone: 317-843-9922 Fax: 317-581-3918 | |
Dr. Steven Marc Paul, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1145 Laurelwood, Carmel, IN 46032 Phone: 317-285-9005 | |
Dr. Sanjay Mishra, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 703 Pro-med Ln, Carmel, IN 46032 Phone: 317-843-9922 Fax: 317-581-3918 | |
Dr. Suman Narasimhamurthy, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 697 Pro-med Ln, Carmel, IN 46032 Phone: 317-574-0055 Fax: 317-674-0059 | |
William Bailey Jones Iii, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 703 Pro-med Ln, Carmel, IN 46032 Phone: 317-843-9922 Fax: 317-581-3918 |